Page last updated: 2024-08-24

naxagolide and cariprazine

naxagolide has been researched along with cariprazine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abi-Dargham, A; Adham, N; Carson, RE; D'Souza, D; Durgam, S; Ghahramani, P; Girgis, RR; Huang, Y; Kapás, M; Kiss, B; Laszlovszky, I; Lee, Y; Nabulsi, N; Periclou, A; Rakhit, A; Slifstein, M	1

Other Studies

1 other study(ies) available for naxagolide and cariprazine

Article	Year
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO. Psychopharmacology, 2016, Volume: 233, Issue:19-20 Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Dopamine; Dopamine Agonists; Drug Partial Agonism; Female; Humans; Male; Middle Aged; Oxazines; Piperazines; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Young Adult	2016

Article

Year

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.

Psychopharmacology, 2016, Volume: 233, Issue:19-20

Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Dopamine; Dopamine Agonists; Drug Partial Agonism; Female; Humans; Male; Middle Aged; Oxazines; Piperazines; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Young Adult

2016